Why tapping the value generated for the next set of therapies is critical.
Irfan Qureshi, MD
Advertisement
Chief Medical Officer at Biohaven Ltd.
Articles by Irfan Qureshi, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5